DOCSLIB.ORG

3 Ketosteroid 9 Alpha-Hydroxylase Enzymes Rieske Non-Heme

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
3 Ketosteroid 9 Alpha-Hydroxylase Enzymes Rieske Non-Heme University of Groningen 3-Ketosteroid 9 alpha-hydroxylase enzymes Petrusma, Mirjan; van der Geize, Robert; Dijkhuizen, Lubbert Published in: Antonie Van Leeuwenhoek: International Journal of General and Molecular Microbiology DOI: 10.1007/s10482-014-0188-2 IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from it. Please check the document version below. Document Version Publisher's PDF, also known as Version of record Publication date: 2014 Link to publication in University of Groningen/UMCG research database Citation for published version (APA): Petrusma, M., van der Geize, R., & Dijkhuizen, L. (2014). 3-Ketosteroid 9 alpha-hydroxylase enzymes: Rieske non-heme monooxygenases essential for bacterial steroid degradation. Antonie Van Leeuwenhoek: International Journal of General and Molecular Microbiology, 106(1), 157-172. https://doi.org/10.1007/s10482-014-0188-2 Copyright Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons). Take-down policy If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately and investigate your claim. Downloaded from the University of Groningen/UMCG research database (Pure): http://www.rug.nl/research/portal. For technical reasons the number of authors shown on this cover page is limited to 10 maximum. Download date: 25-09-2021 Antonie van Leeuwenhoek (2014) 106:157–172 DOI 10.1007/s10482-014-0188-2 INVITED REVIEW Antonie van Leeuwenhoek 80th Anniversary Issue 3-Ketosteroid 9a-hydroxylase enzymes: Rieske non-heme monooxygenases essential for bacterial steroid degradation Mirjan Petrusma • Robert van der Geize • Lubbert Dijkhuizen Received: 30 January 2014 / Accepted: 25 April 2014 / Published online: 21 May 2014 Ó The Author(s) 2014. This article is published with open access at Springerlink.com Abstract Various micro-organisms are able to use further studies on this highly interesting enzyme. sterols/steroids as carbon- and energy sources for Future work may result in the construction of KSH growth. 3-Ketosteroid 9a-hydroxylase (KSH), a two mutants capable of production of specific bioactive component Rieske non-heme monooxygenase com- steroids. Furthermore, KSH provides an promising prised of the oxygenase KshA and the reductase KshB, target for drugs against the pathogenic agent M. is a key-enzyme in bacterial steroid degradation. It tuberculosis. initiates opening of the steroid polycyclic ring struc- ture. The enzyme has industrial relevance in the Keywords 3-Ketosteroid 9a-hydroxylase Á synthesis of pharmaceutical steroids. Deletion of KSH Rieske mono-oxygenase Á 9a-Hydroxylation Á activity in sterol degrading bacteria results in blockage Rhodococcus Á Mycobacterium Á Steroid of steroid ring opening and is used to produce valuable biotransformation C19-steroids such as 4-androstene-3,17-dione and 1,4- androstadiene-3,17-dione. Interestingly, KSH activity is essential for the pathogenicity of Mycobacterium Introduction tuberculosis. Detailed information about KSH thus is of medical relevance, and KSH inhibitory compounds Early observations that microbes are able to degrade may find application in combatting tuberculosis. In cholesterol were made by So¨hngen (1913). Since then, recent years, the 3D structure of the KshA protein of a range of bacteria were found to be able to utilize M. tuberculosis H37Rv has been elucidated and sterols (Arima et al. 1969; Nagasawa et al. 1969), various studies report biochemical characteristics many of which are actinobacteria (e.g. Rhodococcus, and possible physiological roles of KSH. The current Mycobacterium) (Donova 2007; Fernandes et al. knowledge is reviewed here and forms a solid basis for 2003; Malaviya and Gomes 2008 (reviews)). Various enzyme steps in the bacterial sterol degradation pathways remain to be characterized, but in recent M. Petrusma Á R. van der Geize Á L. Dijkhuizen (&) years knowledge on sterol degradation has greatly Department of Microbiology, Groningen Biomolecular increased. A cholesterol catabolism gene cluster was Sciences and Biotechnology Institute (GBB), University identified in R. jostii RHA1 and a cholesterol degra- of Groningen, Nijenborgh 7, 9747 AG Groningen, The Netherlands dation pathway was predicted (Van der Geize et al. e-mail: [email protected] 2007) (Fig. 1). Cholesterol is a C27 sterol and M. Petrusma degradation of its side chain to a C22 intermediate e-mail: [email protected] occurs by a process similar to b-oxidation of fatty 123 158 Antonie van Leeuwenhoek (2014) 106:157–172 Fig. 1 a The basic polycyclic ring structure of sterols and hydroxy-5,9,17-trioxoandrosta-1(10),2-diene-4-oic acid (4,9- steroids with carbon atoms 1–17. b Proposed cholesterol DSHA), 14 9,17-dioxo-1,2,3,4,10,19-hexanorandrostan-5-oic catabolism in Rhodococcus species and Mycobacterium tuber- acid (DOHNAA), 15 2-hydroxyhexa-2,4-diene-oic acid culosis (Adapted from Van der Geize et al. 2007). Dashed (HHD). The compound between brackets is chemically arrows indicate multiple enzymatic steps. The depicted steroids unstable. Hsd 3b-hydroxy steroid dehydrogenase, Cyp 125 are 1 5-cholestene-3b-ol (cholesterol), 2 5-cholestene-26-oic cytochrome P450 CYP125, KstD 3-ketosteroid dehydrogenase, acid-3b-ol, 3 4-cholestene-3-one, 4 4-cholestene-26oic acid-3- KSH 3-ketosteroid 9a-hydroxylase, HsaAB 3-hydroxy-9, one, 5 4-cholestene-24oic acid-3-one, 6 3-oxo-23,24-bisnorch- 10-seconandrost-1,3,5(10)-triene-9,17-dione 4-hydroxylase, ola-4-ene-22-oic acid, 7 4-androstene-3,17-dione (AD), 8 1, HsaC 3,4-dihydroxy-9,10-secoandrost-1,3,5(10)-triene-9,17- 4-androstadiene-3,17-dione (ADD), 9 9a-hydroxy-4-andro- dione dioxygenase, HsaD 4,5–9,10-diseco-3-hydroxy-5,9,17- stene-3,17-dione (9OHAD), 10 9a-hydroxy-1,4-androstadiene- trioxoandrosta-1(10),2-diene-4-oic acid hydrolase. The A, B, 3,17-dione (ADD), 11 3-hydroxy-9,10-secoandrost-1,3,5(10)- C and D ring of the steroid polycyclic ring structure are triene-9,17-dione (3-HSA), 12 3,4-dihydroxy-9,10-secoandrost- indicated in compound 1 (Petrusma 2011) 1,3,5(10)-triene-9,17-dione (3,4-DHSA), 13 4,5–9,10-diseco-3- acids, yielding propionic acid and acetic acid. The actinobacteria Rhodococcus equi (Nocardia restric- subsequent formation of C19 steroids yields another tus) ATCC 14887 (Gibson et al. 1966; Sih et al. 1968), propionic acid (Sih et al. 1968). In M. tuberculosis, R. jostii RHA1 and M. tuberculosis (Van der Geize metabolic labeling studies at carbon atom C26 showed et al. 2007). Several enzymes have been characterized that the propionic acid released from the side chain is a from these organisms as well as from Rhodococcus precursor in the production of phthiocerol dimycoce- erythropolis SQ1 (e.g. Van der Geize et al. 2002), rosate (PDIM), a surface lipid (Ouellet et al. 2010). Nocardia corralina (e.g. Itagaki et al. 1990) and R. The C19 central metabolite derived from cholesterol is rhodochrous DSM43269 (e.g. Petrusma et al. 2009). AD, containing the polycyclic ring structure. Steroid Metabolic labelling studies at carbon atom C4 of ring degradation has been described in some detail for cholesterol in M. tuberculosis revealed that this carbon the Gram-negative bacterium Comamonas testoste- atom in the ring structure is converted to CO2, roni TA441 (Horinouchi et al. 2012) and for the suggesting the generation of energy via the 123 Antonie van Leeuwenhoek (2014) 106:157–172 159 tricarboxylic acid (TCA)-cycle (Pandey and Sassetti chains were detected, suggesting that C17-side chain 2008). Opening of the steroid polycyclic ring structure degradation and opening of the steroid polycyclic ring in these organisms occurs via the so called 9,10-seco structure occur simultaneously (Costa et al. 2013a, b). pathway. Recently, an alternative 2,3-seco pathway Although microbial steroid hydroxylation is well was proposed for aerobic sterol degradation, which documented, starting with the discovery of progester- does not use oxygenase enzymes for side chain one 11a-hydroxylation by a Rhizopus species in 1952 cleavage and for the steroid ring opening event. In (Peterson and Murray 1952), the responsible enzymes the latter case, cleavage of the steroid polycyclic ring are in most cases not known. Over the years, several structure starts with a hydrolytic attack on the A-ring. cytochrome P450 (CYP) enzymes were found to be The proposed pathway is based on identification of involved in steroid hydroxylation (Donova and Egor- cholesterol degradation intermediates in the gram ova 2012 (review); Fernandes et al. 2003 (review); negative bacterium Sterolibacterium denitrificans Holland 1999 (review); Rosłoniec et al. 2009). (Wang et al. 2013). Examples of microbial steroid hydroxylation medi- In actinobacteria, employing the 9,10-seco path- ated by P450 enzymes are 11a-hydroxylation by way, the steroid B-ring is opened by dehydrogenation Rhizopus nigricans (Breskvar et al. 1991), 11b- of the steroid A-ring and by C9a-hydroxylation. The hydroxylation by Curvularia lunata (Suzuki et al. sequence of these reactions is not known. The 1993) and 14a-hydroxylation by Mucor piriformis dehydrogenation step is performed by 3-ketosteroid (Madyastha and Joseph 1993) and the 26/27-hydrox- dehydrogenase enzymes (KSTD) (Itagaki et al. 1990; ylases CYP125 of Rhodococcus jostii RHA1 Knol et al. 2008; Van der Geize et al. 2000), whereas (Rosłoniec et al. 2009) and CYP142 of Mycobacte- 3-ketosteroid 9a-hydroxylase enzymes (KSH) incor- rium tuberculosis (Driscoll et al. 2010). porate a hydroxyl moiety at C9 (Van der Geize et al. Various steroid hydroxylases play a role in micro- 2002).
Load more

Recommended publications
  • (12) United States Patent (10) Patent No.: US 8,323,956 B2 Reardon Et Al
    USOO8323956B2 (12) United States Patent (10) Patent No.: US 8,323,956 B2 Reardon et al. (45) Date of Patent: Dec. 4, 2012 (54) DISTAL TIP OF BIOSENSORTRANSDUCER 6,159,681 A 12/2000 Zebala COMPRISINGENZYME FOR DEAMINATION 6,265,201 B1 7/2001 Wackett et al. 6,271,015 B1* 8/2001 Gilula et al. .................. 435,228 6,284.522 B1 9, 2001 Wackett et al. (75) Inventors: Kenneth F. Reardon, Fort Collins, CO 6,291,200 B1 9, 2001 LeJeune et al. (US); Lawrence Philip Wackett, St. 6,369,299 B1 4/2002 Sadowsky et al. 6.825,001 B2 11/2004 Wackett et al. Paul, MN (US) 7,381,538 B2 * 6/2008 Reardon et al. ................. 435/23 7.595,181 B2 * 9/2009 Gruning et al. ............... 435/197 (73) Assignee: Colorado State University Research 7,709,221 B2 5, 2010 Rose et al. Foundation, Fort Collins, CO (US) 2004/0265811 A1 12/2004 Reardon et al. 2006/0275855 A1 12/2006 Blackburn et al. .............. 435/15 (*) Notice: Subject to any disclaimer, the term of this FOREIGN PATENT DOCUMENTS patent is extended or adjusted under 35 U.S.C. 154(b) by 340 days. WO WOO3,O25892 12/1993 OTHER PUBLICATIONS (21) Appl. No.: 12/358,140 PCT/US2009/040121, International Search Report & Written Opin (22) Filed: Jan. 22, 2009 ion mailed Jul. 14, 2009, 8 pages. Adachi, K., et al; Purification and properties of homogentisate (65) Prior Publication Data oxygenase from Pseudomonas fluorescens. Biochim. Biophys. Acta 118 (1966) 88-97. US 2009/0221014 A1 Sep. 3, 2009 Aldridge, W.N.; Serum esterases.
    [Show full text]
  • Thermophilic Bacteria Are Potential Sources of Novel Rieske Non-Heme
    Chakraborty et al. AMB Expr (2017) 7:17 DOI 10.1186/s13568-016-0318-5 ORIGINAL ARTICLE Open Access Thermophilic bacteria are potential sources of novel Rieske non‑heme iron oxygenases Joydeep Chakraborty, Chiho Suzuki‑Minakuchi, Kazunori Okada and Hideaki Nojiri* Abstract Rieske non-heme iron oxygenases, which have a Rieske-type [2Fe–2S] cluster and a non-heme catalytic iron center, are an important family of oxidoreductases involved mainly in regio- and stereoselective transformation of a wide array of aromatic hydrocarbons. Though present in all domains of life, the most widely studied Rieske non-heme iron oxygenases are found in mesophilic bacteria. The present study explores the potential for isolating novel Rieske non- heme iron oxygenases from thermophilic sources. Browsing the entire bacterial genome database led to the identifi‑ cation of 45 homologs from thermophilic bacteria distributed mainly among Chloroflexi, Deinococcus–Thermus and Firmicutes. Thermostability, measured according to the aliphatic index, showed higher values for certain homologs compared with their mesophilic relatives. Prediction of substrate preferences indicated that a wide array of aromatic hydrocarbons could be transformed by most of the identified oxygenase homologs. Further identification of putative genes encoding components of a functional oxygenase system opens up the possibility of reconstituting functional thermophilic Rieske non-heme iron oxygenase systems with novel properties. Keywords: Rieske non-heme iron oxygenase, Oxidoreductase, Thermophiles, Aromatic hydrocarbons, Biotransformation Introduction of a wide array of agrochemically and pharmaceutically Rieske non-heme iron oxygenases (ROs) constitute a important compounds (Ensley et al. 1983; Wackett et al. large family of oxidoreductase enzymes involved primar- 1988; Hudlicky et al.
    [Show full text]
  • Relating Metatranscriptomic Profiles to the Micropollutant
    1 Relating Metatranscriptomic Profiles to the 2 Micropollutant Biotransformation Potential of 3 Complex Microbial Communities 4 5 Supporting Information 6 7 Stefan Achermann,1,2 Cresten B. Mansfeldt,1 Marcel Müller,1,3 David R. Johnson,1 Kathrin 8 Fenner*,1,2,4 9 1Eawag, Swiss Federal Institute of Aquatic Science and Technology, 8600 Dübendorf, 10 Switzerland. 2Institute of Biogeochemistry and Pollutant Dynamics, ETH Zürich, 8092 11 Zürich, Switzerland. 3Institute of Atmospheric and Climate Science, ETH Zürich, 8092 12 Zürich, Switzerland. 4Department of Chemistry, University of Zürich, 8057 Zürich, 13 Switzerland. 14 *Corresponding author (email: [email protected] ) 15 S.A and C.B.M contributed equally to this work. 16 17 18 19 20 21 This supporting information (SI) is organized in 4 sections (S1-S4) with a total of 10 pages and 22 comprises 7 figures (Figure S1-S7) and 4 tables (Table S1-S4). 23 24 25 S1 26 S1 Data normalization 27 28 29 30 Figure S1. Relative fractions of gene transcripts originating from eukaryotes and bacteria. 31 32 33 Table S1. Relative standard deviation (RSD) for commonly used reference genes across all 34 samples (n=12). EC number mean fraction bacteria (%) RSD (%) RSD bacteria (%) RSD eukaryotes (%) 2.7.7.6 (RNAP) 80 16 6 nda 5.99.1.2 (DNA topoisomerase) 90 11 9 nda 5.99.1.3 (DNA gyrase) 92 16 10 nda 1.2.1.12 (GAPDH) 37 39 6 32 35 and indicates not determined. 36 37 38 39 S2 40 S2 Nitrile hydration 41 42 43 44 Figure S2: Pearson correlation coefficients r for rate constants of bromoxynil and acetamiprid with 45 gene transcripts of ECs describing nucleophilic reactions of water with nitriles.
    [Show full text]
  • Structure-Function Studies of Iron-Sulfur Enzyme Systems
    Structure-Function Studies of Iron-Sulfur Enzyme Systems Rosmarie Friemann Department of Molecular Biology Uppsala Doctoral thesis Swedish University of Agricultural Sciences Uppsala 2005 1 Acta Universitatis Agriculturae Sueciae Agraria 504 ISSN 1401-6249 ISBN 91-576-6783-7 © 2004 Rosmarie Friemann, Uppsala Tryck: SLU Service/Repro, Uppsala 2004 2 Abstract Friemann, R., 2005, Structure-Function Studies of Iron-Sulfur Enzyme Systems. Doctorial dissertation. ISSN 1401-6249, ISBN 91-576-6783-7 Iron-sulfur clusters are among the most ancient of metallocofactors and serve a variety of biological functions in proteins, including electron transport, catalytic, and structural roles. Two kinds of multicomponent enzyme systems have been investigated by X-ray crystallography, the ferredoxin/thioredoxin system and bacterial Rieske non- heme iron dioxygenase (RDO) systems. The ferredoxin/thioredoxin system is a light sensitive system controlling the activities of key enzymes involved in the assimilatory (photosynthetic) and dissimilatory pathways in chloroplasts and photosynthetic bacteria. The system consists of a ferredoxin, ferredoxin:thioredoxin reductase (FTR), and two thioredoxins, Trx-m and Trx-f. In light, photosystem I reduces ferredoxin that reduces Trx-m and Trx- f. This two-electron reduction is catalyzed by FTR that contains a [4Fe-4S] center and a proximal disulfide bridge. When the first electron is delivered by the ferredoxin, an intermediate is formed where one thiol of the proximal disulfide attacks the disulfide bridge of thioredoxin. This results in a transient protein-protein complex held together by a mixed disulfide between FTR and Trx-m. This complex is stabilized by using a C40S mutant Trx-m and its structure have been determined.
    [Show full text]
  • Biotechnological Potential of Rhodococcus Biodegradative Pathways Dockyu Kim1*, Ki Young Choi2, Miyoun Yoo3, Gerben J
    J. Microbiol. Biotechnol. (2018), 28(7), 1037–1051 https://doi.org/10.4014/jmb.1712.12017 Research Article Review jmb Biotechnological Potential of Rhodococcus Biodegradative Pathways Dockyu Kim1*, Ki Young Choi2, Miyoun Yoo3, Gerben J. Zylstra4, and Eungbin Kim5 1Division of Polar Life Sciences, Korea Polar Research Institute, Incheon 21990, Republic of Korea 2University College, Yonsei University, Incheon 21983, Republic of Korea 3Korea Research Institute of Chemical Technology, Daejeon 34114, Republic of Korea 4Department of Biochemistry and Microbiology, School of Environmental and Biological Sciences, Rutgers University, NJ 08901-8520, USA 5Department of Systems Biology, Yonsei University, Seoul 03722, Republic of Korea Received: December 8, 2017 Revised: March 26, 2018 The genus Rhodococcus is a phylogenetically and catabolically diverse group that has been Accepted: May 1, 2018 isolated from diverse environments, including polar and alpine regions, for its versatile ability First published online to degrade a wide variety of natural and synthetic organic compounds. Their metabolic May 8, 2018 capacity and diversity result from their diverse catabolic genes, which are believed to be *Corresponding author obtained through frequent recombination events mediated by large catabolic plasmids. Many Phone: +82-32-760-5525; rhodococci have been used commercially for the biodegradation of environmental pollutants Fax: +82-32-760-5509; E-mail: [email protected] and for the biocatalytic production of high-value chemicals from low-value materials.
    [Show full text]
  • Monohydroxylation of Phenoland 2,5-Dichlorophenol by Toluene
    APPLIED AND ENVIRONMENTAL MICROBIOLOGY, OCt. 1989, p. 2648-2652 Vol. 55, No. 10 0099-2240/89/102648-05$02.00/0 Copyright © 1989, American Society for Microbiology Monohydroxylation of Phenol and 2,5-Dichlorophenol by Toluene Dioxygenase in Pseudomonas putida Fl J. C. SPAIN,1* G. J. ZYLSTRA,2 C. K. BLAKE,2 AND D. T. GIBSON2 Air Force Engineering and Services Laboratory, Tyndall Air Force Base, Florida 32403,1 and Department of Microbiology, University of Iowa, Iowa City, Iowa 522422 Received 13 April 1989/Accepted 21 July 1989 Pseudomonas putida Fl contains a multicomponent enzyme system, toluene dioxygenase, that converts toluene and a variety of substituted benzenes to cis-dihydrodiols by the addition of one molecule of molecular oxygen. Toluene-grown cells of P. putida Fl also catalyze the monohydroxylation of phenols to the corresponding catechols by an unknown mechanism. Respirometric studies with washed cells revealed similar enzyme induction patterns in cells grown on toluene or phenol. Induction of toluene dioxygenase and subsequent enzymes for catechol oxidation allowed growth on phenol. Tests with specific mutants of P. putida Fl indicated that the ability to hydroxylate phenols was only expressed in cells that contained an active toluene dioxygenase enzyme system. 1802 experiments indicated that the overall reaction involved the incorporation of only one atom of oxygen in the catechol, which suggests either a monooxygenase mechanism or a dioxygenase reaction with subsequent specific elimination of water. The phenomenon of enzymatic oxygen fixation was first P. putida F39/D is a mutant strain of P. putida Fl that described in 1955 (11, 15).
    [Show full text]
  • OSHA Permissible Exposure Limits (Pels) Are Too Permissive
    Permissible Exposure Limits Copyright © 2018 Ronald N. Kostoff OSHA Permissible Exposure Limits (PELs) are too Permissive. by Dr. Ronald N. Kostoff Research Affiliate, School of Public Policy, Georgia Institute of Technology Gainesville, VA, 20155 Email: [email protected] KEYWORDS Permissible Exposure Limits; Exposure Limits; No-adverse-effects-exposure-limits; Minimal Risk Levels; NOAEL; OSHA; NIOSH; ACGIH; ATSDR 1 Permissible Exposure Limits Copyright © 2018 Ronald N. Kostoff CITATION TO MONOGRAPH Kostoff RN. OSHA Permissible Exposure Limits (PELs) are too Permissive. Georgia Institute of Technology. 2018. PDF. http://hdl.handle.net/1853/60067 COPYRIGHT AND CREATIVE COMMONS LICENSE COPYRIGHT Copyright © 2018 by Ronald N. Kostoff Printed in the United States of America; First Printing, 2018 CREATIVE COMMONS LICENSE This work can be copied and redistributed in any medium or format provided that credit is given to the original author. For more details on the CC BY license, see: http://creativecommons.org/licenses/by/4.0/ This work is licensed under a Creative Commons Attribution 4.0 International License<http://creativecommons.org/licenses/by/4.0/>. DISCLAIMERS The views in this monograph are solely those of the author, and do not represent the views of the Georgia Institute of Technology. 2 Permissible Exposure Limits Copyright © 2018 Ronald N. Kostoff TABLE OF CONTENTS TITLE KEYWORDS CITATION TO MONOGRAPH COPYRIGHT CREATIVE COMMONS LICENSE DISCLAIMERS ABSTRACT INTRODUCTION Background Relation of Biomedical Literature Findings to Setting of Exposure Limits Structure of Monograph ANALYSIS Overview Substance Selection Strategy Table 1 RESULTS AND DISCUSSION R-1. Acetaldehyde R-2. Trichloroethylene R-3. Naphthalene R-4. Dimethylbenzene R-5. Carbon Disulfide Interim Summary R-6.
    [Show full text]
  • A Direct Electrode-Driven P450 Cycle for Biocatalysis
    Proc. Natl. Acad. Sci. USA Vol. 94, pp. 13554–13558, December 1997 Biochemistry A direct electrode-driven P450 cycle for biocatalysis VYTAUTAS REIPA,MARTIN P. MAYHEW, AND VINCENT L. VILKER* Biotechnology Division, National Institute of Standards and Technology, Gaithersburg, MD 20899 Communicated by Ronald W. Estabrook, University of Texas Southwestern Medical Center, Dallas, TX, October 8, 1997 (received for review June 27, 1997) ABSTRACT The large potential of redox enzymes to carry Research into the use of electrodes to supply the reducing out formation of high value organic compounds motivates the power for driving P450 catalytic cycles is being actively pursued search for innovative strategies to regenerate the cofactors (9–13). Estabrook and coworkers (9) (University of Texas needed by their biocatalytic cycles. Here, we describe a bio- Southwestern Medical Center at Dallas) have shown mediated reactor where the reducing power to the cycle is supplied electrode-driven biocatalysis using cobalt(III) sepulchrate to directly to purified cytochrome CYP101 (P450cam; EC transfer electrons to a rat recombinant liver P450 fusion 1.14.15.1) through its natural redox partner (putidaredoxin) protein, whereas Kazlauskaite et al. (10) and Zhang et al. (11) using an antimony-doped tin oxide working electrode. Re- have demonstrated direct electron transfer from carbon-based quired oxygen was produced at a Pt counter electrode by water electrodes to CYP101 (P450cam). In the mediated biocatalysis electrolysis. A continuous catalytic cycle was sustained for studies, the electrolysis enzyme turnover rate was comparable more than 5 h and 2,600 enzyme turnovers. The maximum with the NADPH-driven cycle for a number of recombinant product formation rate was 36 nmol of 5-exo-hydroxycam- fusion microsomal P450 enzymes (12).
    [Show full text]
  • A Mass Balance Field Study of the Phytoremediation of Trichloroethylene with Transgenic Poplars Genetically Modified with Cytochrome P450 2E1
    A Mass Balance Field Study of the Phytoremediation of Trichloroethylene with Transgenic Poplars Genetically Modified with Cytochrome P450 2E1 Emily K. Legault A thesis submitted in partial fulfillment of the requirements for the degree of Master of Science in Civil Engineering University of Washington 2013 Committee: Stuart Strand Dave Stahl Sharon Doty Program Authorized to Offer Degree: Civil and Environmental Engineering ©Copyright 2013 Emily K. Legault Table of Contents 1 Abstract .................................................................................................................................... 1 2 Introduction ............................................................................................................................. 2 3 Materials and Methods ............................................................................................................ 6 3.1 Field Site Description ....................................................................................................... 6 3.2 Water Management and Chemical Dosing....................................................................... 7 3.3 Water Sampling and Analysis .......................................................................................... 7 3.4 Soil Sampling and Analysis ............................................................................................. 9 3.5 Soil and Stem Volatilization .......................................................................................... 10 3.6 Evapotranspiration ........................................................................................................
    [Show full text]
  • 12) United States Patent (10
    US007635572B2 (12) UnitedO States Patent (10) Patent No.: US 7,635,572 B2 Zhou et al. (45) Date of Patent: Dec. 22, 2009 (54) METHODS FOR CONDUCTING ASSAYS FOR 5,506,121 A 4/1996 Skerra et al. ENZYME ACTIVITY ON PROTEIN 5,510,270 A 4/1996 Fodor et al. MICROARRAYS 5,512,492 A 4/1996 Herron et al. 5,516,635 A 5/1996 Ekins et al. (75) Inventors: Fang X. Zhou, New Haven, CT (US); 5,532,128 A 7/1996 Eggers Barry Schweitzer, Cheshire, CT (US) 5,538,897 A 7/1996 Yates, III et al. s s 5,541,070 A 7/1996 Kauvar (73) Assignee: Life Technologies Corporation, .. S.E. al Carlsbad, CA (US) 5,585,069 A 12/1996 Zanzucchi et al. 5,585,639 A 12/1996 Dorsel et al. (*) Notice: Subject to any disclaimer, the term of this 5,593,838 A 1/1997 Zanzucchi et al. patent is extended or adjusted under 35 5,605,662 A 2f1997 Heller et al. U.S.C. 154(b) by 0 days. 5,620,850 A 4/1997 Bamdad et al. 5,624,711 A 4/1997 Sundberg et al. (21) Appl. No.: 10/865,431 5,627,369 A 5/1997 Vestal et al. 5,629,213 A 5/1997 Kornguth et al. (22) Filed: Jun. 9, 2004 (Continued) (65) Prior Publication Data FOREIGN PATENT DOCUMENTS US 2005/O118665 A1 Jun. 2, 2005 EP 596421 10, 1993 EP 0619321 12/1994 (51) Int. Cl. EP O664452 7, 1995 CI2O 1/50 (2006.01) EP O818467 1, 1998 (52) U.S.
    [Show full text]
  • SGM Meeting Abstracts
    CONTENTS Page MAIN SYMPOSIUM New challenges to health: the threat of virus infection 3 GROUP SYMPOSIUM CELLS & CELL SURFACES GROUP Wall-less organisms 5 Offered posters 7 CLINICAL MICROBIOLOGY GROUP Antibiotic resistance 9 Offered posters 12 CLINICAL VIROLOGY GROUP Monitoring and treatment of blood-borne viral infections 17 EDUCATION GROUP Benchmarking in microbiology 23 ENVIRONMENTAL MICROBIOLOGY GROUP Microbe/pollutant interactions: biodegradation and bioremediation 25 Offered posters 30 FERMENTATION & BIOPROCESSING and PHYSIOLOGY, BIOCHEMISTRY & MOLECULAR GENETICS GROUPS Biotransformations 41 Offered posters 43 MICROBIAL INFECTION GROUP joint with BIOCHEMICAL SOCIETY New enzyme targets for antimicrobial agents 49 Offered posters 51 MICROBIAL INFECTION GROUP Activities and actions of antimicrobial peptides 55 Offered posters 57 PHYSIOLOGY, BIOCHEMISTRY & MOLECULAR GENETICS GROUP Microbiology of nitric oxide 59 Offered posters 61 SYSTEMATICS & EVOLUTION GROUP joint with INTERNATIONAL COMMITTEE ON SYSTEMATIC BACTERIOLOGY Genomics: Beyond the sequence 65 Offered posters 68 VIRUS GROUP Post-transcriptional control of virus gene expression 71 INDEX OF AUTHORS 79 LATE SUBMISSIONS 83 Society for General Microbiology – 148th Ordinary Meeting – Heriot-Watt University – 26-30 March 2001 - 1 - Society for General Microbiology – 148th Ordinary Meeting – Heriot-Watt University – 26-30 March 2001 - 2 - Main Symposium New challenges to health: the threat of virus infection Full chapters of the following presentations will be published in a Symposium - New challenges to health: the threat of virus infection – published for the Society for General Microbiology by Cambridge University Press. MONDAY 26 MARCH 2001 0900 Surveillance and detection of viruses C.J. PETERS (Centers for Disease Control & Prevention, Atlanta) 0945 Dynamics and epidemiological impact of microparasites B. GRENFELL (University of Cambridge) 1100 The emergence of human immunodeficiency viruses and AIDS R.
    [Show full text]
  • (E) Fluorination
    US 20090061471 A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2009/0061471 A1 Fasan et al. (43) Pub. Date: Mar. 5, 2009 (54) METHODS AND SYSTEMS FOR SELECTIVE Publication Classification FLUORINATION OF ORGANIC MOLECULES (51) Int. Cl. (76) Inventors: Rudi Fasan, Brea, CA (US); CI2O I/26 (2006.01) Frances H. Arnold, La Canada, CA CI2P 7/62 (2006.01) (US) CI2P 7/38 (2006.01) CI2P I 7/04 (2006.01) Correspondence Address: CI2P I 7/14 (2006.01) Joseph R. Baker, APC CI2P 9/44 (2006.01) Gavrilovich, Dodd & Lindsey LLP 4660 La Jolla Village Drive, Suite 750 (52) U.S. Cl. ........... 435/25; 435/135; 435/149; 435/126; San Diego, CA 92122 (US) 435/120: 435/74 (21) Appl. No.: 11/890,218 (22) Filed: Aug. 4, 2007 (57) ABSTRACT A method and system for selectively fluorinating organic Related U.S. Application Data molecules on a target site wherein the target site is activated (60) Provisional application No. 60/835,613, filed on Aug. and then fluorinated are shown together with a method and 4, 2006. system for identifying a molecule having a biological activity. OH DeOXO- F Oxygenase 1 fluorination HO F Oxygenase 2 DeOXO Sea-intries fluOrination Oxygenase 3 HO H F O F DeOXO (e) ---->fluorination Patent Application Publication Mar. 5, 2009 Sheet 1 of 8 US 2009/0061471 A1 OH DeOXO- F ov fluorination HO F Oxygenase 2 DeOXO - - -m-m-e- fluorination on N HO OH F DeOXO fluorination FI G. 1 Chemo-enzymatic strategy F Oxygenase OH DeOXO fluorination High regio- and stereoselectivity Highly enantiopure fluoro derivative in good yields Chemical Strategy F F FIUOrination (OE FChiral -m-ap reSOIUtion (o) Enantiopurein poor fluoro-derivative yields Poor Stereoselectivity With Current methods FIG.
    [Show full text]